Continuous Glucose Monitoring: Key Facts and Uses

Continuous glucose monitoring (CGM) has revolutionized diabetes management by providing real-time, detailed glucose data that surpasses traditional fingerstick testing. This technology offers continuous insight into glucose trends, enabling better control of blood sugar levels and reducing the risk of complications associated with diabetes1 . With advances in sensor accuracy and usability, CGM has become an essential tool for many people with diabetes, improving quality of life and clinical outcomes2 .

How Continuous Glucose Monitoring Works

Continuous glucose monitoring systems consist of three main components: a sensor, a transmitter, and a receiver or display device. The sensor is a small, thin device inserted just under the skin, usually on the abdomen or upper arm, where it measures glucose levels in the interstitial fluid—the fluid surrounding body cells that closely reflects blood glucose concentrations3 . The sensor is held in place by an adhesive patch and typically lasts from 7 to 15 days, depending on the model4 .

The transmitter wirelessly sends glucose data from the sensor to a receiver, which can be a smartphone app, a dedicated handheld device, or an insulin pump with compatible technology. These systems provide glucose readings every 1 to 15 minutes, offering semi-continuous data that reveal patterns and trends invisible to intermittent fingerstick testing3 . Some CGMs require a warm-up period before data transmission begins, and while older models needed frequent fingerstick calibration, many modern devices are factory-calibrated, reducing user burden3 4.

CGM devices often include customizable alerts that warn users of impending hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar), allowing timely intervention. The data can be downloaded and shared with healthcare providers to optimize diabetes management3 4.

• Sensor insertion is quick and minimally invasive, using an applicator to place the sensor under the skin3 .
• Glucose measurements are taken in the interstitial fluid, which closely follows blood glucose but may lag by a few minutes4 .
• Data transmission is wireless and continuous, enabling real-time monitoring and trend analysis3 .
• CGM systems store glucose data over hours to days, facilitating pattern recognition and treatment adjustments3 .
• Fingerstick checks may still be needed to confirm CGM accuracy during symptoms or alerts3 .

“Continuous glucose monitoring systems (CGMS) are not just better, more accurate glucometers. They provide real-time data and can predict glucose changes and patterns over time.”

— Jyothi Gogineni, MD, Northwestern Medicine5

CGM Eligibility and Requirements

Continuous glucose monitoring is primarily prescribed for people with diabetes who require close glucose management. International consensus guidelines recommend CGM for individuals with type 1 diabetes, those experiencing hypoglycemia unawareness, and patients with problematic glycemic control despite optimized therapy6 . CGM use is expanding to include people with type 2 diabetes, especially those on insulin therapy or with frequent hypoglycemia6 7.

Eligibility criteria often depend on clinical need, insurance coverage, and patient factors. For example, Medicare recently expanded CGM coverage to include all insulin-treated diabetes patients and those with a history of problematic hypoglycemia, regardless of insulin use8 . A healthcare provider's prescription and documentation of medical necessity are typically required to initiate CGM therapy6 8.

CGM devices and usage plans should be individualized based on:

• Patient age and diabetes type6 .
• Treatment regimen, including insulin use6 .
• Personal preferences and lifestyle considerations6 .
• Duration of use, ranging from short-term diagnostic to long-term management6 .
• Professional (blinded) CGM may be used temporarily for treatment optimization6 .

Access to CGM remains inconsistent globally due to cost and insurance barriers, but ongoing efforts aim to improve availability6 9.

• CGM requires a prescription and is usually initiated by a healthcare provider6 .
• Insurance coverage varies and may require evidence of medical necessity6 10.
• CGM is especially recommended for patients on intensive insulin regimens or with frequent hypoglycemia6 .
• Some CGMs are now available over the counter for adults with type 2 diabetes or prediabetes without insulin use11 .
• Selection of the appropriate CGM device should consider patient-specific factors6 .

CGM Benefits and Advantages

Continuous glucose monitoring offers numerous benefits over traditional fingerstick blood glucose testing. By providing comprehensive, real-time glucose data, CGM enables better glycemic control, reduces hypoglycemia risk, and improves quality of life for people with diabetes2 12. It allows users and clinicians to identify glucose patterns, variability, and trends that inform personalized treatment adjustments13 .

Key advantages of CGM include:

• Real-time alerts for low and high glucose levels, facilitating timely interventions and preventing emergencies14 .
• Reduction in the frequency of fingerstick blood glucose checks, decreasing patient burden4 .
• Improved glycemic control, demonstrated by significant reductions in HbA1c and increased time in range (TIR) 215.
• Enhanced patient satisfaction and quality of life through better glucose awareness and control2 .
• Ability to share glucose data remotely with healthcare providers or family members, supporting collaborative care3 9.

Studies show that CGM combined with insulin pump therapy can lower mean HbA1c from 8.35% to 7.0%, increase TIR to nearly 68%, and reduce emergency room visits dramatically over several years15 . CGM is also valuable during pregnancy and for patients with hypoglycemia unawareness6 16.

• CGM provides a more complete picture of glucose fluctuations throughout the day and night17 .
• Alerts help prevent severe hypoglycemia, which can cause seizures, coma, or death if untreated14 .
• CGM data supports personalized insulin dosing and lifestyle modifications3 .
• Continuous monitoring can reduce hospitalizations and long-term diabetes complications2 9.
• CGM use is associated with increased treatment satisfaction and reduced diabetes distress2 .

“CGMS devices are getting smaller; the interface technology is improving. The data can more easily be sent to your physician to inform your care.”

— Douglas L. Ambler, MD, Northwestern Medicine5

CGM Limitations and Considerations

Despite its benefits, CGM technology has limitations that users and clinicians should consider. Sensor accuracy, calibration requirements, cost, and user experience remain challenges to widespread adoption3 10. While many modern CGMs are factory-calibrated, some still require periodic fingerstick calibration to ensure accuracy, especially during symptoms or alerts3 .

Cost is a significant barrier, as CGM devices and supplies can be expensive. Annual expenses for sensors and transmitters may reach several thousand dollars without insurance coverage, and reimbursement policies vary widely by country and insurer10 . Public insurance programs often have restrictive criteria, limiting access for many patients10 9.

Other considerations include:

• Potential skin irritation or allergic reactions to adhesives18 .
• Alarm fatigue from frequent or false alerts, which may cause distress or disrupt sleep18 .
• The constant presence of a sensor attached to the body, which some users find inconvenient18 .
• Information overload, as the volume of data can be overwhelming and may increase diabetes distress18 .
• Certain medications and supplements (e.g., acetaminophen, ascorbic acid) can affect sensor accuracy4 .

CGM data metrics such as Time in Range (TIR), Time Above Range (TAR), and Time Below Range (TBR) provide more meaningful glycemic control indicators beyond HbA1c, but interpreting these requires education and clinical support19 13.

• CGM systems may occasionally provide inaccurate readings, necessitating confirmation with fingerstick tests14 .
• Usability and clear instructions are critical for successful adoption and sustained use20 .
• CGM does not replace the need for clinical follow-up and therapy adjustments6 .
• Some patients may experience adhesive-related skin issues requiring management18 .
• Cost and insurance coverage remain the biggest hurdles to broader CGM use10 .

Continuous glucose monitoring offers a comprehensive view of glucose trends, alerting users to dangerous highs and lows. However, cost and sensor accuracy challenges limit access and require ongoing support for optimal use. 1014

When to Consult Your Doctor

Regular consultation with a healthcare provider is essential when using CGM to ensure safe and effective diabetes management. Providers help determine if CGM is appropriate, prescribe the device, and educate patients on its use and data interpretation6 . Follow-up visits assess device performance, glycemic outcomes, and any issues such as skin reactions or alarm fatigue6 .

Patients should contact their healthcare provider if they experience:

• Persistent or severe hypoglycemia or hyperglycemia despite CGM use14 .
• Symptoms that do not match CGM readings, indicating possible sensor inaccuracies3 .
• Skin irritation, allergic reactions, or problems with sensor adhesion18 .
• Difficulty understanding or managing CGM data and alerts6 .
• Concerns about device malfunction or data transmission issues3 .

Insurance coverage often requires documentation of medical necessity and periodic evaluation, making provider involvement critical for ongoing access6 10.

• Discuss CGM initiation and suitability with your healthcare provider6 .
• Report any unusual symptoms or discrepancies between CGM and fingerstick readings3 .
• Seek advice for managing device-related skin or usability problems18 .
• Ensure regular follow-up to optimize therapy based on CGM data6 .
• Contact your provider promptly if you experience severe glucose abnormalities14 .

Key Takeaways and Summary

• Continuous glucose monitoring provides real-time, detailed glucose data by measuring interstitial fluid glucose every few minutes, offering a comprehensive view of glycemic patterns beyond fingerstick testing3 4.
• CGM is recommended for people with type 1 diabetes, insulin-treated type 2 diabetes, hypoglycemia unawareness, and those with problematic glycemic control despite optimized therapy6 8.
• Benefits of CGM include improved glycemic control, reduced hypoglycemia, enhanced quality of life, and the ability to personalize diabetes management through trend analysis and alerts2 15.
• Limitations include cost, insurance coverage barriers, potential sensor inaccuracies, calibration needs, skin irritation, and alarm fatigue, which require patient education and clinical support10 18.
• Regular consultation with healthcare providers is vital for device selection, education, data interpretation, and addressing any complications or concerns during CGM use6 .